设计,合成和评估mupirocin前药物,恢复对MRSA的全身疗效
Zhi Gong1, Ruixue Zhang1, Linpu Yang1
1School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, Chongqing, 401331, PR China.
European journal of medicinal chemistry
|November 29, 2025
概括
穆皮罗前药物克服了系统性使用的快速降解. 一种胆固醇二硫化原药 (3d) 的半衰期延长了6倍,在肺部感染中具有强大的抗MRSA活性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 传染性疾病 传染性疾病
背景情况:
- 穆皮罗辛是一种强效的抗生素,由于其快速的血降解和短半衰期,仅限于局部使用.
- 血中的酶降解限制了mupirocin在细菌感染中的系统治疗潜力.
研究的目的:
- 设计和合成mupirocin前药物,以增强系统输送的药物动力学特性.
- 在细菌感染的临床前模型中评估mupirocin前药物的疗效.
主要方法:
- 合理设计的mupirocin前药物使用酶分离的链剂向碳酸.
- 通过选择性雌性化与脂性部分的合成和使用NMR和HRMS进行表征.
- 在小鼠肺部感染模型中对抗菌疗效的药理动力学评估和评估.
主要成果:
- 与mupirocin相比,主要前药3d (胆固醇-二硫化物链接剂) 的血半衰期增加了6倍.
- 化合物3d在度-时间曲线 (AUC) 下的肺部面积增加了1356倍.
- 3d在系统性和中性衰竭的小鼠肺部感染模型中显示出强大的抗甲基西林耐药黄金葡萄球菌 (MRSA) 疗效.
结论:
- 前药物策略有效地克服了mupirocin的药理动力学限制,使其能够系统应用.
- 穆皮罗辛前药具有治疗系统性细菌感染的巨大潜力,特别是MRSA.
- 这种方法验证了用于增强抗生素系统生物可用性和疗效的前期药物开发.
更多相关视频
06:42Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
2.6K
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
2.3K
相关概念视频
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:30Prodrugs
3.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.8K
01:28Antimicrobial Effectiveness
883
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
883